SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, and the French Kidney Cancer Research Network collaborated on a study using a multimodal algorithm to help predict post-operative outcomes for those facing renal cell carcinoma, with the results recently published in npj Precision Oncology.
AI model developed by SOPHiA GENETICS and UroCCR predicts post-operative outcomes in kidney cancer study
- Thread starter Educator
- Start date